Tesidolumab (LFG316) 是一种全人IgG1/λ抗c5单克隆抗体，分子量为143 kDa(不含糖基化)。Tesidolumab (LFG316)阻断C5的切割，防止膜攻击复合体的后续形成。
| 生物活性 |
Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation). Tesidolumab (LFG316) blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex[1].
|
体外研究
(In Vitro) |
Tesidolumab (LFG316) possesses a half-life in humans of approximately 9 days. Tesidolumab (LFG316) binds to a distinct epitope to that of eculizumab and ravulizumab, distant to Arg 885[1].
|
| CAS 号 |
|
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis.
|
m.cnreagent.com
